Paper - WANFANG MED ONLINE

You Position: Home > Paper

肠道微生态与慢性胰腺炎

( views:175, downloads:205 )

Author:: No author available

Journal Title:: Chinese Journal of Pancreatology

Issue:: 6

DOI:: 10.3760/cma.j.issn.1674-1935.2019.06.020

Key Word:: 肠道微生态;慢性胰腺炎;益生菌;粪菌移植

Abstract：肠道微生物因其在人类健康和疾病中的作用而日益受到人们的重视.初步证据表明,肠道微生物失调与多种胰腺疾病有关.慢性胰腺炎患者肠道微生态的变化情况已有少量文献报道.靶向调控微生物可能具有治疗价值.

Reference

[1]Jan Bures,Jiri Cyrany,Darina Kohoutova,etc.Small intestinal bacterial overgrowth syndrome[J].2010,(24).
[2]Rebeca, Martín,Sylvie, Miquel,Florian, Chain,etc.Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.[J].2015,15.
[3]Whitcomb, David C.,Frulloni, Luca,Garg, Pramod,etc.Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition[J].2016,16(2).
[4]Filipe De Vadder,Petia Kovatcheva-Datchary,Daisy Goncalves,etc.Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits[J].2014,156(1/2).
[5]Sonnenburg, Erica D.,Smits, Samuel A.,Tikhonov, Mikhail,etc.Diet-induced extinctions in the gut microbiota compound over generations[J].2016,529(Jan.14 TN.7585).
[6]Sherman PM,Gareau MG,Walker WA.Probiotics and the gut microbiota in intestinal health and disease.[J].2010,7(9).
[7]Cani PD,Amar J,Iglesias MA,etc.Metabolic endotoxemia initiates obesity and insulin resistance.[J].2007,56(7).
[8]Tang,W.H.W.,Wang,Z.,Levison,B.S.,etc.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J].2013,368(17).
[9]Khadijeh, Abhari,Seyed Shahram, Shekarforoush,Saeid, Hosseinzadeh,etc.The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats.[J].2016.
[10]Paramsothy, Sudarshan,Kamm, Michael A.,Kaakoush, Nadeem O.,etc.Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial[J].2017,389(10075).
[11]Christina L, Ohland,Wallace K, Macnaughton.Probiotic bacteria and intestinal epithelial barrier function.[J].2010,298(6).
[12]Jiunn-Wei,Wang,Chao-Hung,Kuo,Fu-Chen,Kuo,etc.Fecal microbiota transplantation: Review and update.[J].2018.
[13]Quraishi, M. N.,Widlak, M.,Bhala, N.,etc.Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection[J].2017,46(5).
[14]Gevers, Dirk,Kugathasan, Subra,Denson, Lee A.,etc.The Treatment-Naive Microbiome in New-Onset Crohn's Disease[J].2014,15(3).
[15]Shinji Fukuda,Hidehiro Toh,Koji Hase,etc.Bifidobacteria can protect from enteropathogenic infection through production of acetate[J].2011,469(Jan.27 TN.7331).
[16]Duba,M.,Cloney,D.,Kunde,S.,etc.Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis[J].2013,56(6).
[17]Huang, Ying,Liu, Changjun,Cao, Youde,etc.Dysbiosis of Intestinal Microbiota Associated With Inflammation Involved in the Progression of Acute Pancreatitis[J].2015,44(6).
[18]Alexeev, Erica E.,Lanis, Jordi M.,Kao, Daniel J.,etc.Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor[J].2018,188(5).
[19]Servin AL.Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens[J].2004,28(4).
[20]Turnbaugh PJ,Ley RE,Mahowald MA,etc.An obesity-associated gut microbiome with increased capacity for energy harvest[J].2006,444(7122).
[21]Oriana, Rossi,Lisette A, van Berkel,Florian, Chain,etc.Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.[J].2016.
[22]Ahmadi-Vand, Zahra,Lochner, Arion,Godovannyi, Artem,etc.Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice[J].2016,10(2).
[23]Knight R,Keilbaugh SA,Bushman F,etc.High-fat diet determines the composition of the murine gut microbiome independently of obesity.[J].2009,137(5).
[24]Marianna, Signoretti,Roberta, Roggiolani,Caterina, Stornello,etc.Gut microbiota and pancreatic diseases.[J].2017,(Spec ).
[25]Shanmiao, Gou,Zhiyong, Yang,Tao, Liu,etc.Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials.[J].2014,18(2).
[26]Danilo, Pagliari,Ciriaco A, Piccirillo,Anis, Larbi,etc.The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases.[J].2015,2015.
[27]Venkata S,Akshintala,Rupjyoti,Talukdar,Vikesh K,Singh,etc.The Gut Microbiome in Pancreatic Disease.[J].2018.
[28]Steck N,Hoffmann M,Sava IG,etc.Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation.[J].2011,141(3).
[29]Gabriele Capurso.Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis[J].2016,(5).
[30]Tian, Hongliang,Ding, Chao,Gong, Jianfeng,etc.Treatment of Slow Transit Constipation With Fecal Microbiota Transplantation: A Pilot Study[J].2016,50(10).
[31]Sharma B,Srivastava S,Singh N,etc.Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial.[J].2011,45(5).
[32]Bruneau A,Rabot S,Raymond F,etc.Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.[J].2010,24(12).
[33]Becker, Christoph,Neurath, Markus F.,Wirtz, Stefan.The Intestinal Microbiota in Inflammatory Bowel Disease[J].2015,56(2).
[34]Curtis Huttenhower,Dirk Gevers,Rob Knight,etc.Structure, function and diversity of the healthy human microbiome[J].2012,486(Jun.14 TN.7402).
[35]Sha,S.,Liang,J.,Chen,M.,etc.Systematic review: Faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children[J].2014,39(10).
[36]Samuel, BS,Shaito, A,Motoike, T,etc.Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41[J].2008,105(43).
[37]Talley NJ,Moayyedi P,Ford AC,etc.Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.[J].2009,7(12).
[38]Nicholas Arpaia,Clarissa Campbell,Xiying Fan,etc.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation[J].2013,504(Dec.26 TN.7480).
[39]Bruce A. Roe,Micah Hamady,Alexis Duncan,etc.A Core Gut Microbiome In Obese And Lean Twins[J].2009,457(7228).
[40]Junjie Qin,Ruiqiang Li,Raes, Jeroen,etc.A human gut microbial gene catalogue established by metagenomic sequencing.[J].2010,464(7285).
[41]Louis, P,Flint, HJ.Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine[J].2009,294(1).
[42]Gaboriau Routhiau V,Rakotobe S,Lecuyer E.The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses.[J].2009,31(4).
[43]Fernando Cobo,Javier Rodríguez-Granger,Antonio Sampedro,etc.Infected breast cyst due to Prevotella buccae resistant to metronidazole[J].2017,48.
[44]Chunsaie, Wang,Jingna, Li.Pathogenic Microorganisms and Pancreatic Cancer.[J].2015,2.
[45]Blanc V,Tatoud R,Rothwell A,etc.Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice[J].2006,103(33).
[46].Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial[J].2008,23(6).
[47]Ebrahim Kouchaki,Omid Reza Tamtaji,Mahmoud Salami,etc.Clinical and metabolic response to probiotic supplementation in?patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial[J].2017,36(5).
[48]Jun, Chen,Kerry, Wright,John M, Davis,etc.An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.[J].2016.
[49]A, Oláh,T, Belágyi,A, Issekutz,etc.Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis.[J].2002,89(9).
[50]Wang, Jun,Thingholm, Louise B.,Skieceviciene, Jurgita,etc.Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota[J].2016,48(11).
[51]Vanessa K, Ridaura,Jeremiah J, Faith,Federico E, Rey,etc.Gut microbiota from twins discordant for obesity modulate metabolism in mice.[J].2013,341(6150).
[52].A High-Fat High-Sucrose Diet Rapidly Alters Muscle Integrity, Inflammation and Gut Microbiota in Male Rats.[J].2016,6(Spec).
[53]Stefanía, Magnúsdóttir,Dmitry, Ravcheev,Valérie, de Crécy-Lagard,etc.Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes.[J].2015,6.
[54]GUIDO J. BAKKER,MAX NIEUWDORP.Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyondClostridium difficile[J].2017,5(4).
[55]Sai Manasa, Jandhyala,A, Madhulika,G, Deepika,etc.Altered intestinal microbiota in patients with chronic pancreatitis: implications in diabetes and metabolic abnormalities.[J].2017,7(Spec ).
[56]D C, Savage,J E, Siegel,J E, Snellen,etc.Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms.[J].1981,42(6).
[57]Cai, H. -F.,Xu, J.,Li, Y. -T.,etc.Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection[J].2016,43(4).
[58]Sartor, R. Balfour,Wu, Gary D..Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches[J].2017,152(2).
[59]Guilloteau, P.,Martin, L.,Eeckhaut, V.,etc.From the gut to the peripheral tissues: the multiple effects of butyrate[J].2010,23(2).
[60]Borenstein, E.,Greenblum, S.,Turnbaugh, P.J..Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease[J].2012,109(2).
[61].Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis.[J].2018,8(1).